Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation

Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Pharmaceutics - Volume 549, Issues 1–2, 5 October 2018, Pages 388-396

Shin Jung Park, Prakash Thapa, Hye-Jin Seo, Eun Seok Park, Seong Hoon Jeong,